CORRESP 1 filename1.htm

 

October 10, 2024

 

VIA EDGAR

 

Office of Life Sciences

Division of Corporation Finance

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 

Attention: Tyler Howes

 

Re:

PaxMedica, Inc.

Acceleration Request for Registration Statement on Form S-1

File No. 333-282488

 

Dear Mr. Howes:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), PaxMedica, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to October 15, 2024, at 5:15 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Harris Beach PLLC, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.

 

If you have any questions regarding this request, please contact Scot Foley of Harris Beach PLLC at +1 (716) 200-5108.

 

Sincerely,  
   
PAXMEDICA, INC.  
   
/s/ Howard Weisman  
Howard Weisman  
Chief Executive Officer  

 

cc: Scot Foley, Harris Beach PLLC